Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
Janice WangFeinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USANegin HajizadehFeinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USAErnest E. MooreDepartment of Surgery, Ernest E Moore Shock Trauma Center at Denver Health, Denver, CO, USARobert C. McIntyreDepartment of Surgery, University of Colorado Denver, Aurora, CO, USAPeter K. MooreDepartment of Medicine, University of Colorado Denver, Aurora, CO, USALivia A. VeressDepartment of Pediatrics, Pulmonary Medicine, University of Colorado Denver, Aurora, CO, USAMichael B. YaffeCenter for Precision Cancer Medicine, Departments of Biological Engineering and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USAHunter B. MooreDepartment of Surgery, University of Colorado Denver, Aurora, CO, USAChristopher D. BarrettCenter for Precision Cancer Medicine, Departments of Biological Engineering and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA
2020en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба